This article is
- freely available
Hypertensive Emergency in Aortic Dissection and Thoracic Aortic Aneurysm—A Review of Management
Division of Cardiothoracic and Vascular Surgery, Creighton University Medical Center, Omaha, NE 68131, USA
* Author to whom correspondence should be addressed.
Received: 10 August 2009; in revised form: 21 September 2009 / Accepted: 27 September 2009 / Published: 28 September 2009
Abstract: Over the last few decades, treatment for aortic dissection and thoracic aortic aneurysms has evolved significantly with improvement in outcomes. Treatment paradigms include medical, endovascular and surgical options. As aortic dissection presents as a hypertensive emergency, diligent control of BP is of utmost importance in order to reduce the progression of dissection with possible aortic branch malperfusion. Treatment should begin on arrival to the emergency department and continues in the intensive care unit, endovascular suite or the operating room. Novel antihypertensive medications with improved pharmacological profile and improved surgical techniques, have improved the prognosis of patients with aortic aneurysm and/or aortic dissection. Nevertheless, morbidity and mortality remain high and hypertensive emergency poses a significant challenge in aortic dissection and thoracic aortic aneurysms.
Keywords: hypertension; emergency; aortic; aneurysm; dissection
Article StatisticsClick here to load and display the download statistics.
Notes: Multiple requests from the same IP address are counted as one view.
Cite This Article
MDPI and ACS Style
Gupta, P.K.; Gupta, H.; Khoynezhad, A. Hypertensive Emergency in Aortic Dissection and Thoracic Aortic Aneurysm—A Review of Management. Pharmaceuticals 2009, 2, 66-76.
Gupta PK, Gupta H, Khoynezhad A. Hypertensive Emergency in Aortic Dissection and Thoracic Aortic Aneurysm—A Review of Management. Pharmaceuticals. 2009; 2(3):66-76.
Gupta, Prateek K.; Gupta, Himani; Khoynezhad, Ali. 2009. "Hypertensive Emergency in Aortic Dissection and Thoracic Aortic Aneurysm—A Review of Management." Pharmaceuticals 2, no. 3: 66-76.